News tagged with joint inflammation

Xeljanz approved for rheumatoid arthritis

(HealthDay)—Xeljanz (tofacitinib) has been approved by the U.S. Food and Drug Administration to treat symptoms of rheumatoid arthritis (RA) among people who can't tolerate, or haven't been helped by, the drug methotrexate.

Nov 07, 2012
popularity not rated yet | comments 0

Using antibodies against immune deficiency

Early, intensive therapy with a biotechnologically produced medication can provide significantly faster pain relief for patients with rheumatic joint inflammation. Damage to joints can also be reduced when the medication ...

Sep 27, 2012
popularity not rated yet | comments 0

New animal model for rheumatoid arthritis

Researchers at Northwestern University Feinberg School of Medicine have created the first animal model that spontaneously develops rheumatoid arthritis (RA) and is predisposed towards atherosclerosis, or hardening of the ...

Jun 28, 2012
popularity not rated yet | comments 0

Better understanding arthritis

Better arthritis treatment could be one step closer with research showing muscle inflammation outside joints as much to blame for discomfort and poor mobility in sufferers as inflammation of the joint itself.

May 02, 2012
popularity not rated yet | comments 0
  • Pages: 1 2